Multiparametric magnetic resonance imaging for the differential diagnosis between granulomatous prostatitis and prostate cancer: a literature review to an intriguing diagnostic challenge.
PI-RADS score
granulomatous prostatitis
granulomatous prostatitis induced by BCG
multiparametric magnetic resonance imaging
non-specific granulomatous prostatitis
prostate cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
02
03
2023
accepted:
22
05
2023
medline:
21
6
2023
pubmed:
21
6
2023
entrez:
21
6
2023
Statut:
epublish
Résumé
Multiparametric magnetic resonance imaging (mpMRI) is currently the most effective diagnostic tool for detecting prostate cancer (PCa) and evaluating adenocarcinoma-mimicking lesions of the prostate gland, among which granulomatous prostatitis (GP) represents the most interesting diagnostic challenge. GP consists of a heterogeneous group of chronic inflammatory lesions that can be differentiated into four types: idiopathic, infective, iatrogenic, and associated with systemic granulomatous disease. The incidence of GP is growing due to the increase in endourological surgical interventions and the adoption of intravesical instillation of Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer; therefore, the difficulty lies in identifying specific features of GP on mpMRI to avoid the use of transrectal prostate biopsy as much as possible.
Identifiants
pubmed: 37342186
doi: 10.3389/fonc.2023.1178430
pmc: PMC10277616
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1178430Informations de copyright
Copyright © 2023 Gaudiano, Renzetti, De Fino, Corcioni, Ciccarese, Bianchi, Schiavina, Droghetti, Giunchi, Brunocilla and Fiorentino.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Radiol. 2013 Jun;68(6):595-9
pubmed: 23384503
Insights Imaging. 2021 Jun 16;12(1):79
pubmed: 34132898
Ultraschall Med. 2005 Jun;26(3):203-8
pubmed: 15948056
J Urol. 2017 Feb;197(2S):S142-S145
pubmed: 28012770
Korean J Radiol. 2022 Jan;23(1):60-67
pubmed: 34983094
Diagnostics (Basel). 2022 Sep 23;12(10):
pubmed: 36291991
Br J Radiol. 2019 Jun;92(1098):20180075
pubmed: 30964700
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
Abdom Radiol (NY). 2017 Jul;42(7):1956-1962
pubmed: 28238033
J Cancer Res Ther. 2021 Jul;17(3):625-629
pubmed: 34269291
Future Sci OA. 2020 Jun 17;6(7):FSO591
pubmed: 32802396
Mol Clin Oncol. 2015 Jan;3(1):249-251
pubmed: 25469304
Future Oncol. 2020 May;16(13):805-806
pubmed: 32180450
Radiographics. 2016 Jan-Feb;36(1):162-75
pubmed: 26587887
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
Clin Imaging. 2014 Sep-Oct;38(5):755-7
pubmed: 24852675
Br J Radiol. 2022 Mar 1;95(1131):20210916
pubmed: 34919421
Abdom Radiol (NY). 2017 Jul;42(7):1963-1967
pubmed: 28224172
Diagn Interv Imaging. 2013 Jan;94(1):84-90
pubmed: 23079151
Korean J Radiol. 2015 Mar-Apr;16(2):342-8
pubmed: 25741196
Clin Genitourin Cancer. 2020 Dec;18(6):e684-e687
pubmed: 32389459